169 related articles for article (PubMed ID: 21133121)
1. Tablets containing drug-loaded polymeric nanocapsules: an innovative platform.
Friedrich RB; Bastos MO; Fontana MC; Ourique AF; Beck RC
J Nanosci Nanotechnol; 2010 Sep; 10(9):5885-8. PubMed ID: 21133121
[TBL] [Abstract][Full Text] [Related]
2. Drying polymeric drug-loaded nanocapsules: the wet granulation process as a promising approach.
Friedrich RB; Fontana MC; Bastos MO; Pohlmann AR; Guterres SS; Beck RC
J Nanosci Nanotechnol; 2010 Jan; 10(1):616-21. PubMed ID: 20352901
[TBL] [Abstract][Full Text] [Related]
3. Sublingual tablets containing spray-dried carvedilol-loaded nanocapsules: development of an innovative nanomedicine.
Chaves PS; Dos Santos J; Pohlmann AR; Guterres SS; Beck RCR
Pharm Dev Technol; 2020 Nov; 25(9):1053-1062. PubMed ID: 32558594
[TBL] [Abstract][Full Text] [Related]
4. 3D printed tablets loaded with polymeric nanocapsules: An innovative approach to produce customized drug delivery systems.
Beck RCR; Chaves PS; Goyanes A; Vukosavljevic B; Buanz A; Windbergs M; Basit AW; Gaisford S
Int J Pharm; 2017 Aug; 528(1-2):268-279. PubMed ID: 28583328
[TBL] [Abstract][Full Text] [Related]
5. Hydrogel containing dexamethasone-loaded nanocapsules for cutaneous administration: preparation, characterization, and in vitro drug release study.
Marchiori ML; Lubini G; Dalla Nora G; Friedrich RB; Fontana MC; Ourique AF; Bastos MO; Rigo LA; Silva CB; Tedesco SB; Beck RC
Drug Dev Ind Pharm; 2010 Aug; 36(8):962-71. PubMed ID: 20590450
[TBL] [Abstract][Full Text] [Related]
6. Enhanced oral bioavailability of fenofibrate using polymeric nanoparticulated systems: physicochemical characterization and in vivo investigation.
Yousaf AM; Kim DW; Oh YK; Yong CS; Kim JO; Choi HG
Int J Nanomedicine; 2015; 10():1819-30. PubMed ID: 25784807
[TBL] [Abstract][Full Text] [Related]
7. The effect of polymeric binder type and concentration on flow and dissolution properties of SMEDDS loaded mesoporous silica-based granules.
Kovačević M; Zvonar Pobirk A; German Ilić I
Eur J Pharm Sci; 2024 Feb; 193():106582. PubMed ID: 37709174
[TBL] [Abstract][Full Text] [Related]
8. In vitro determination of aceclofenac Mouth Dissolving Tablets.
Shobhit S; Gupta SK
Polim Med; 2013; 43(4):227-9. PubMed ID: 24596037
[TBL] [Abstract][Full Text] [Related]
9. Preparation of redispersible dry nanocapsules by means of spray-drying: development and characterisation.
Tewa-Tagne P; Briançon S; Fessi H
Eur J Pharm Sci; 2007 Feb; 30(2):124-35. PubMed ID: 17150339
[TBL] [Abstract][Full Text] [Related]
10. Formulation of controlled-release baclofen matrix tablets: influence of some hydrophilic polymers on the release rate and in vitro evaluation.
Abdelkader H; Abdalla OY; Salem H
AAPS PharmSciTech; 2007 Nov; 8(4):E100. PubMed ID: 18181521
[TBL] [Abstract][Full Text] [Related]
11. [Influence of polymer type on the physical properties and the release study of papaverine hydrochloride from tablets].
Kasperek R; Polski A; Sobótka-Polska K; Poleszak E
Polim Med; 2014; 44(1):5-12. PubMed ID: 24918651
[TBL] [Abstract][Full Text] [Related]
12. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules.
Mehta S; De Beer T; Remon JP; Vervaet C
Int J Pharm; 2012 Jan; 422(1-2):310-7. PubMed ID: 22101283
[TBL] [Abstract][Full Text] [Related]
13. [Application of β-cyclodextrin in the formulation of ODT tablets containing ibuprofen].
Zimmer Ł; Kasperek R; Poleszak E
Polim Med; 2014; 44(4):231-5. PubMed ID: 25932904
[TBL] [Abstract][Full Text] [Related]
14. Assessing the In Vitro Drug Release from Lipid-Core Nanocapsules: a New Strategy Combining Dialysis Sac and a Continuous-Flow System.
de Andrade DF; Zuglianello C; Pohlmann AR; Guterres SS; Beck RC
AAPS PharmSciTech; 2015 Dec; 16(6):1409-17. PubMed ID: 25986595
[TBL] [Abstract][Full Text] [Related]
15. Formulation, development, and performance evaluation of metoclopramide HCl oro-dispersible sustained release tablet.
Kasliwal N; Negi JS; Jugran V; Jain R
Arch Pharm Res; 2011 Oct; 34(10):1691-700. PubMed ID: 22076769
[TBL] [Abstract][Full Text] [Related]
16. Disintegrants combination: development and optimization of a cefadroxil fast disintegrating tablet.
Rahim N; Naqvi SB; Bibi R; Iffat W; Shakeel S; Muhammad IN
Pak J Pharm Sci; 2014 Sep; 27(5 Spec no):1467-75. PubMed ID: 25176230
[TBL] [Abstract][Full Text] [Related]
17. [The use of semi-synthetic polymers in the formulation of sucking and chewable tablets containing sage extract and zinc gluconate].
Linka WA; Golenia E; Zgoda MM; Kołodziejczyk MK
Polim Med; 2014; 44(4):237-45. PubMed ID: 25932905
[TBL] [Abstract][Full Text] [Related]
18. Development of oral dispersible tablets containing prednisolone nanoparticles for the management of pediatric asthma.
Chen YD; Liang ZY; Cen YY; Zhang H; Han MG; Tian YQ; Zhang J; Li SJ; Yang DS
Drug Des Devel Ther; 2015; 9():5815-25. PubMed ID: 26640367
[TBL] [Abstract][Full Text] [Related]
19. Formulation and optimization of orodispersible tablets of diazepam.
Abed KK; Hussein AA; Ghareeb MM; Abdulrasool AA
AAPS PharmSciTech; 2010 Mar; 11(1):356-61. PubMed ID: 20232267
[TBL] [Abstract][Full Text] [Related]
20. Development of orally disintegrating tablets of Perphenazine/hydroxypropyl-β-cyclodextrin inclusion complex.
Wang L; Zeng F; Zong L
Pharm Dev Technol; 2013; 18(5):1101-10. PubMed ID: 22759202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
